Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

670

Figures (1-4)

119

Tables (1-2)

113

Sum=936

Publishing Process of This Article

Item

Count

Browse

Download

236

Sum=289

May 15, 2024 (publication date) through Nov 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. May 15, 2024; 16(5): 1833-1848
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1833

Full Size Figure Download Figure

Figure 1 Comparison of overall survival between the two groups.

Citation: Mu F, Hu LS, Xu K, Zhao Z, Yang BC, Wang YM, Guo K, Shi JH, Lv Y, Wang B. Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome. World J Gastrointest Oncol 2024; 16(5): 1833-1848
URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1833.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1833